Who
David Brian Perez
Director
Company insider
Files Form 4 as: Director, NeoGenomics; Director, Ortho Clinical Diagnostics Holdings; Director, Mesa Laboratories.
In numbers
- Trades disclosed
- 27
- Buys
- 1
- Sells
- 0
- Bought
- $76K
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 7 Nov 2019
- Last trade
- 1 Jun 2026
- Last filed
- 3 Jun 2026
Companies traded
Activity over time
1 May 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jun 2026filed 3 Jun 2026 | NEO NeoGenomicsProfessional Services | SEC FORM 4 Code M | —23,077 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | NEO NeoGenomicsoption or derivative · Professional Services | SEC FORM 4 Code M | —23,077 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | NEO NeoGenomicsoption or derivative · Professional Services | SEC FORM 4 Code A | —11,069 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | NEO NeoGenomicsoption or derivative · Professional Services | SEC FORM 4 Code M | —23,077 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | NEO NeoGenomicsoption or derivative · Professional Services | SEC FORM 4 Code A | —11,069 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | NEO NeoGenomicsoption or derivative · Professional Services | SEC FORM 4 Code A | —15,970 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | NEO NeoGenomicsoption or derivative · Professional Services | SEC FORM 4 Code A | —15,970 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | NEO NeoGenomicsProfessional Services | SEC FORM 4 Code M | —23,077 at $0.00 | filing |
| 1 Jun 2025filed 3 Jun 2025 | NEO NeoGenomicsoption or derivative · Professional Services | SEC FORM 4 Code M | —12,254 at $0.00 | filing |
| 1 Jun 2025filed 3 Jun 2025 | NEO NeoGenomicsoption or derivative · Professional Services | SEC FORM 4 Code A | —16,107 at $0.00 | filing |
| 1 Jun 2025filed 3 Jun 2025 | NEO NeoGenomicsoption or derivative · Professional Services | SEC FORM 4 Code A | —23,077 at $0.00 | filing |
| 1 Jun 2025filed 3 Jun 2025 | NEO NeoGenomicsProfessional Services | SEC FORM 4 Code M | —12,254 at $0.00 | filing |
| 5 May 2025filed 7 May 2025 | NEO NeoGenomicsProfessional Services | SEC FORM 4 Bought | $76K10,000 at $7.63 | filing |
| 10 Aug 2024filed 13 Aug 2024 | NEO NeoGenomicsoption or derivative · Professional Services | SEC FORM 4 Code M | —11,336 at $0.00 | filing |
| 10 Aug 2024filed 13 Aug 2024 | NEO NeoGenomicsProfessional Services | SEC FORM 4 Code M | —11,336 at $0.00 | filing |
| 1 Jun 2024filed 4 Jun 2024 | NEO NeoGenomicsoption or derivative · Professional Services | SEC FORM 4 Code A | —8,672 at $0.00 | filing |
| 1 Jun 2024filed 4 Jun 2024 | NEO NeoGenomicsoption or derivative · Professional Services | SEC FORM 4 Code A | —12,254 at $0.00 | filing |
| 10 Aug 2023filed 14 Aug 2023 | NEO NeoGenomicsoption or derivative · Professional Services | SEC FORM 4 Code A | —8,353 at $0.00 | filing |
| 10 Aug 2023filed 14 Aug 2023 | NEO NeoGenomicsoption or derivative · Professional Services | SEC FORM 4 Code A | —11,336 at $0.00 | filing |
| 3 Nov 2022filed 7 Nov 2022 | NEO NeoGenomicsoption or derivative · Professional Services | SEC FORM 4 Code A | —9,730 at $0.00 | filing |
News
NeoGenomics, Inc. (NASDAQ:NEO) Stock Has Average Target Price of $17.67NEO · tickerreport.com · 9 Oct 2026
0 headlines in the last 90 days name David Brian Perez; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.